000 01749 a2200481 4500
005 20250517000012.0
264 0 _c20150812
008 201508s 0 0 eng d
022 _a1879-291X
024 7 _a10.1016/j.ultrasmedbio.2014.06.014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeguerney, Ingrid
245 0 0 _aMolecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin.
_h[electronic resource]
260 _bUltrasound in medicine & biology
_cJan 2015
300 _a197-207 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aContrast Media
_xpharmacokinetics
650 0 4 _aEndoglin
650 0 4 _aFemale
650 0 4 _aIntegrin alphaV
_xmetabolism
650 0 4 _aIntracellular Signaling Peptides and Proteins
_xmetabolism
650 0 4 _aMelanoma
_xdiagnostic imaging
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aMolecular Imaging
_xmethods
650 0 4 _aNiacinamide
_xanalogs & derivatives
650 0 4 _aPhenylurea Compounds
_xtherapeutic use
650 0 4 _aSorafenib
650 0 4 _aTreatment Outcome
650 0 4 _aUltrasonography
_xmethods
650 0 4 _aVascular Endothelial Growth Factor Receptor-2
_xmetabolism
700 1 _aScoazec, Jean-Yves
700 1 _aGadot, Nicolas
700 1 _aRobin, Nina
700 1 _aPénault-Llorca, Frédérique
700 1 _aVictorin, Steeve
700 1 _aLassau, Nathalie
773 0 _tUltrasound in medicine & biology
_gvol. 41
_gno. 1
_gp. 197-207
856 4 0 _uhttps://doi.org/10.1016/j.ultrasmedbio.2014.06.014
_zAvailable from publisher's website
999 _c24272294
_d24272294